These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11815410)

  • 1. Waf-1 (p21) and p53 polymorphisms in breast cancer.
    Keshava C; Frye BL; Wolff MS; McCanlies EC; Weston A
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):127-30. PubMed ID: 11815410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
    Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP17 genotype and breast cancer risk.
    Weston A; Pan CF; Bleiweiss IJ; Ksieski HB; Roy N; Maloney N; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):941-4. PubMed ID: 9796640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.
    Mechanic LE; Millikan RC; Player J; de Cotret AR; Winkel S; Worley K; Heard K; Heard K; Tse CK; Keku T
    Carcinogenesis; 2006 Jul; 27(7):1377-85. PubMed ID: 16399771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
    Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 haplotype determination in breast cancer.
    Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
    Wu MT; Chen MC; Wu DC
    Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
    Wu X; Zhao H; Amos CI; Shete S; Makan N; Hong WK; Kadlubar FF; Spitz MR
    J Natl Cancer Inst; 2002 May; 94(9):681-90. PubMed ID: 11983757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.
    Göhring UJ; Bersch A; Becker M; Neuhaus W; Schöndorf T
    J Clin Pathol; 2001 Nov; 54(11):866-70. PubMed ID: 11684722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
    Ziv E; John EM; Choudhry S; Kho J; Lorizio W; Perez-Stable EJ; Burchard EG
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1878-85. PubMed ID: 17035394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.
    Su L; Sai Y; Fan R; Thurston SW; Miller DP; Zhou W; Wain JC; Lynch TJ; Liu G; Christiani DC
    Lung Cancer; 2003 Jun; 40(3):259-66. PubMed ID: 12781424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.
    Keku T; Millikan R; Worley K; Winkel S; Eaton A; Biscocho L; Martin C; Sandler R
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1611-21. PubMed ID: 12496052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups.
    Birgander R; Själander A; Saha N; Spitsyn V; Beckman L; Beckman G
    Hum Hered; 1996; 46(3):148-54. PubMed ID: 8860009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
    Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
    Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators.
    Ceccarelli C; Santini D; Chieco P; Lanciotti C; Taffurelli M; Paladini G; Marrano D
    Int J Cancer; 2001 Mar; 95(2):128-34. PubMed ID: 11241324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
    Connor AE; Baumgartner RN; Baumgartner KB; Kerber RA; Pinkston C; John EM; Torres-Mejia G; Hines L; Giuliano A; Wolff RK; Slattery ML
    Breast Cancer Res Treat; 2012 Nov; 136(2):593-602. PubMed ID: 23085767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21(WAF-1/CIP-1), a downstream regulator of functional p53 loss, in transitional cell carcinoma of urothelium.
    Ozdemir E; Kakehi Y; Yoshida O
    Eur Urol; 2000 Aug; 38(2):230-4. PubMed ID: 10895017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.
    Powell BL; van Staveren IL; Roosken P; Grieu F; Berns EM; Iacopetta B
    Carcinogenesis; 2002 Feb; 23(2):311-5. PubMed ID: 11872638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.